Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Nature
|
July 20, 2018
The shieldin complex mediates 53BP1-dependent DNA repair
Sylvie M Noordermeer, Salomé Adam, Dheva Setiaputra, et al.
Scientific Reports
|
July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
Harriett Holme, Aditi Gulati, Rachel Brough, et al.
Scientific Reports
|
August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
Harriett Holme, Aditi Gulati, Rachel Brough, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cancer Research
|
October 16, 2024
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
Asuka Kawai-Kawachi, Madison M Lenormand, Clémence Astier, et al.
American Journal of Human Genetics
|
March 28, 2017
De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome
Sandra Jansen, Sinje Geuer, Rolph Pfundt, et al.
Cell Reports. Medicine
|
October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Cancer Research
|
February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L Flaherty, Flavia Hughes, George Sflomos, et al.
Molecular Cancer Therapeutics
|
July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations
Anh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance
Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Nature
|
July 20, 2018
The shieldin complex mediates 53BP1-dependent DNA repair
Sylvie M Noordermeer, Salomé Adam, Dheva Setiaputra, et al.
Scientific Reports
|
July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
Harriett Holme, Aditi Gulati, Rachel Brough, et al.
Scientific Reports
|
August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness
Harriett Holme, Aditi Gulati, Rachel Brough, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cancer Research
|
October 16, 2024
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
Asuka Kawai-Kawachi, Madison M Lenormand, Clémence Astier, et al.
American Journal of Human Genetics
|
March 28, 2017
De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome
Sandra Jansen, Sinje Geuer, Rolph Pfundt, et al.
Cell Reports. Medicine
|
October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Cancer Research
|
February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma
Renée L Flaherty, Flavia Hughes, George Sflomos, et al.
Molecular Cancer Therapeutics
|
July 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations
Anh Minh Tran Huynh, Jonathan T Lei, Rachel Brough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance
Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Page
of 7